AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

RTMS Targets Neural Circuits for Smoking Cessation

RecruitingNAAges 22 Years - 70 YearsAllMedical University of South Carolina
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, investigators will use brain MRI to guide TMS therapy for smoking cessation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria * Be between the ages of 22 and 70 years old. * Smoke 10 or more cigarettes per day and have a carbon monoxide (CO) level \> 10 ppm indicative of recent smoking. * Have not received substance abuse treatment within the previous 30 days. * Meet the criteria for tobacco use disorder as determined by DSM-5. * Be in stable mental and physical health. * If female, test non-pregnant and use adequate birth control. * Show no evidence of focal or diffuse brain lesions on MRI. * Be willing to provide informed consent. * Be able to comply with protocol requirements and likely to complete all study procedures. * Be motivated to quit smoking (based on responses of "very likely," or "somewhat likely" in the motivation questionnaire). Exclusion Criteria * Current moderate to severe substance use of any psychoactive substances other than nicotine or caffeine, as defined by DSM-V criteria. * Contraindications to MRI (e.g., presence of metal in the skull, orbital or intracranial cavity, or having claustrophobia). * Contraindication to rTMS. * History of autoimmune, endocrine, viral, or vascular disorders affecting the brain. * History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment. * Unstable cardiac disease, uncontrolled hypertension, severe renal or liver insufficiency, or sleep apnea. * Lifetime history of major Axis I disorders such as: bipolar affective disorder (BPAD), schizophrenia, post-traumatic stress disorder (PTSD), dementia, suicidal ideation or major depression. * Self-report of \>21 standard alcohol drinks per week in any week in the 30 days prior to screening. * Use of other forms of nicotine delivery, such as nicotine patches, electronic cigarettes, gum, nasal spray, inhalers, and nicotine lozenges. * Use of other tobacco products, including cigars, cigarillos, chew, snuff, and pouches/snus. * Previous treatment with TMS.
๐Ÿ’Š

What it tests

  • Sham rTMS
  • Active rTMS 10 Hz DLPFC
๐Ÿ“

Where

2 sites
Medical University of South Carolina
Charleston, United States
Medical University of South Carolina
Charleston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy